114 related articles for article (PubMed ID: 7678377)
1. Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study.
Nisijima K; Ishiguro T
Biol Psychiatry; 1993 Jan; 33(1):45-8. PubMed ID: 7678377
[TBL] [Abstract][Full Text] [Related]
2. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].
Nishijima K; Ishiguro T
Seishin Shinkeigaku Zasshi; 1989; 91(6):429-56. PubMed ID: 2479043
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic malignant syndrome: a study of CSF monoamine metabolism.
Nisijima K; Ishiguro T
Biol Psychiatry; 1990 Feb; 27(3):280-8. PubMed ID: 1689186
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome.
Nisijima K; Ishiguro T
J Psychiatr Res; 1995; 29(3):233-44. PubMed ID: 7473299
[TBL] [Abstract][Full Text] [Related]
5. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid.
Geracioti TD; Keck PE; Ekhator NN; West SA; Baker DG; Hill KK; Bruce AB; Wortman MD
Biol Psychiatry; 1998 Aug; 44(3):228-33. PubMed ID: 9693394
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
Mignot E; Laude D; Elghozi JL
J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
[TBL] [Abstract][Full Text] [Related]
7. The dopamine-serotonin relationship in clozapine response.
Szymanski S; Lieberman J; Pollack S; Munne R; Safferman A; Kane J; Kronig M; Cooper T
Psychopharmacology (Berl); 1993; 112(1 Suppl):S85-9. PubMed ID: 7530378
[TBL] [Abstract][Full Text] [Related]
8. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
9. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
[TBL] [Abstract][Full Text] [Related]
10. Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL).
Argentiero V; Tavolato B
J Neurol; 1980; 224(1):53-8. PubMed ID: 6157799
[TBL] [Abstract][Full Text] [Related]
11. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.
Polinsky RJ; Brown RT; Burns RS; Harvey-White J; Kopin IJ
J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):914-9. PubMed ID: 2462617
[TBL] [Abstract][Full Text] [Related]
12. CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome.
Earley CJ; Hyland K; Allen RP
Mov Disord; 2001 Jan; 16(1):144-9. PubMed ID: 11215576
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Nader MA; Barrett JE
Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to neuroleptic malignant syndrome in Parkinson's disease.
Ueda M; Hamamoto M; Nagayama H; Otsubo K; Nito C; Miyazaki T; Terashi A; Katayama Y
Neurology; 1999 Mar; 52(4):777-81. PubMed ID: 10078727
[TBL] [Abstract][Full Text] [Related]
15. Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
Barkai AI; Kowalik S; Reches A
Psychopharmacology (Berl); 1984; 84(3):352-5. PubMed ID: 6083575
[TBL] [Abstract][Full Text] [Related]
16. Reye syndrome: monoamine metabolites in ventricular fluid.
Shaywitz BA; Venes J; Cohen DJ; Bowers MB
Neurology; 1979 Apr; 29(4):467-72. PubMed ID: 571546
[TBL] [Abstract][Full Text] [Related]
17. Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.
Salomon RM; Kennedy JS; Johnson BW; Urbano Blackford J; Schmidt DE; Kwentus J; Gwirtsman HE; Gouda JF; Shiavi RG
Neuropsychopharmacology; 2005 Nov; 30(11):2082-91. PubMed ID: 15856079
[TBL] [Abstract][Full Text] [Related]
18. Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children.
Kuśmierska K; Szymańska K; Rokicki D; Kotulska K; Jóźwiak S; Sykut-Cegielska J; Mierzewska H; Szczepanik E; Pronicka E; Demkow U
Adv Exp Med Biol; 2016; 878():73-82. PubMed ID: 26453071
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
20. [Monoamine imbalance of the central nervous system in a case of Shy-Drager syndrome with recurrent attacks of a neuroleptic malignant syndrome].
Ueda M; Hamamoto M; Otsubo K; Miyazaki T; Terashi A
Rinsho Shinkeigaku; 1996 May; 36(5):696-8. PubMed ID: 8905993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
